Clinician Challenges In Infertility Diagnosis
Joseph Chervenak, MD, MBA, begins a discussion surrounding innovative processes in reproductive medicine.
Joseph Chervenak, MD, MBA, discusses the complexities in diagnosing infertility, highlighting the challenge of fitting individual experiences into clinical definitions. The American Society of Reproductive Medicine (ASRM) redefined infertility to be more inclusive, acknowledging diverse patient needs, including those of same-sex couples. The primary hurdle in treatment lies in the prohibitive cost of in vitro fertilization (IVF), despite its high success rates. The discussion emphasizes the psychosocial strains during IVF, such as financial burdens and lacking support systems for patients. Additionally, the expert explores the limitations faced by vulnerable populations, like cancer patients, who struggle with the potential risks to their reproductive health due to the toxicity of cancer treatments. The concept of "financial toxicity" impacting quality of life due to medical expenses is highlighted, prompting a call for more comprehensive evaluation and investment in psychological support services in the field of reproductive health. The importance of not solely focusing on technology but also emphasizing the human aspect of care is underscored, advocating for a holistic approach.
Video synopsis is AI-generated and reviewed by Managed Health Care Executive editorial staff.
Evolving Role of Statins in Managing CV Risk in HIV | ID Week 2024
October 18th 2024Statins have had an evolving role in the management of cardiovascular risk in people living with HIV, explained Michelle Cespedes, M.D., M.S., professor of medicine, Icahn School of Medicine at Mount Sinai and Mount Sinai Health System.
Read More
Fertility Treatments Found to Be Equally Effective in Females with PCOS as in Those Without
December 18th 2023In a study recently published in the journal Fertility and Sterility, researchers from the University of Queensland in Brisbane, Australia, evaluated the fertility treatment pathways used by participants with and without PCOS to determine which pathways resulted in more live births.
Read More
